Events Search and Views Navigation
March 2019
Gene Therapies for Rare Disorders Summit
Mark Trusheim will present: Precision Fiancing Framework and Pilots: MIT FoCUS Consortium Findings
Find out more »April 2019
Harvard-MIT Center for Regulatory Science Annual Symposium
12:00 PM Panel: Towards an “Agile” Regulatory Framework (45 mins) Chaired by Gigi Hirsch, Massachusetts Institute of Technology Including: Paul Howard, Food and Drug Administration Anne-Virginie Eggimann, bluebird bio Ed Pezalla, Enlightenment Bioconsult John Ferguson, Sanofi
Find out more »May 2019
American Society of Pediatric Hematology/Oncology (ASPHO) Symposium
Mark Trusheim for FoCUS
Find out more »June 2019
Rare Disease Innovation & Partnering Summit
"Delve into the Evolving Reimbursement Landscape and Developments in Payer Policy" Mark Trushiem for FoCUS
Find out more »HFMA Annual Conference
Jane Barlow for the FoCUS Project
Find out more »September 2019
Managed Care Risk Association Annual Conference
Colin Young for the FoCUS Project
Find out more »February 2021
MIT Sloan 2021 Healthcare and Bioinnovations Conference
NEWDIGS Executive Director Gigi Hirsch moderated the midday keynote fireside chat at the MIT Sloan 2021 Healthcare and Bioinnovations Conference, on the topic "The Value of Downstream Innovation - Improving Patient Access to Groundbreaking Therapies".
Find out more »March 2021
Gene Therapy for Blood Disorders Virtual Conference
Mark Trusheim spoke at on the panel "Collecting & Utilizing Data to Support Gene Therapy Market Access" at the 4th Annual Gene Therapy for Rare Disorders conference representing FoCUS.
Find out more »June 2021
BCBSA 2021 Specialty Pharmacy Conference
Mark Trusheim participated in the BCBSA 2021 Specialty Pharmacy Conference on July 20–21.
Find out more »May 2023
ISPOR 2023: From Concept to Practice: How to Tactically Design a Feasible Outcomes-Based Contract in Oncology?
The LEAPS Project is excited to announce that a workshop session proposal submitted by Mark Trusheim, NEWDIGS Strategic Director, and Jamie Foley, Global Director of Value-Based Innovation, at Takeda Pharmaceuticals, has been accepted for the upcoming ISPOR 2023 conference in Boston on May 7-10, 2023. The workshop, titled “From Concept to Practice: How to Tactically Design a Feasible Outcomes-Based Contract in Oncology?”, will drill down on specific components intrinsic to the tactical design of a successful outcomes-based contract in oncology…
Find out more »